CymaBay Therapeutics Inc
(NASDAQ:CBAY)
$19.7988
0.0888[0.45%]
Last update: 4:28PM (Delayed 15-Minutes)
Get Real Time Here
$19.7988
0[0.00%]
After-Hours
Open19.500Close20.360
Vol / Avg.2.747M / 2.298MMkt Cap2.245B
Day Range19.440 - 20.70052 Wk Range3.380 - 19.880

CymaBay Therapeutics Stock (NASDAQ:CBAY) Earnings Dates and Earning Calls

CymaBay Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Nov 7

EPS

$-0.320

Quarterly Revenue

$0K

Annual Revenue (as of Sep 30)

$31M

Earnings Recap

CymaBay Therapeutics (NASDAQ:CBAY) reported its Q3 earnings results on Tuesday, November 7, 2023 at 04:04 PM.

Here's what investors need to know about the announcement.

Earnings

CymaBay Therapeutics missed estimated earnings by 6.67%, reporting an EPS of $-0.32 versus an estimate of $-0.3.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.19 which was followed by a 3.94% increase in the share price the next day.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings History

Analyze the earnings history of CymaBay Therapeutics using advanced sorting and filters.

Date
time
ticker
Quarter
Prior EPS
Est EPS
Actual EPS
EPS Surprise
Prior Rev
Est Rev
Actual Rev
Rev Surprise
Get Alert
11/07/2023PMCBAYQ3-$0.28-$0.30-$0.32-6.67%$0.00$0.00Get Alert
08/10/2023PMCBAYQ2-$0.31-$0.20-$0.0195.00%$0.00$9.90M$31.02M213.29%Get Alert
05/15/2023PMCBAYQ1-$0.32-$0.09-$0.29-222.22%$0.00$21.35M$0.00-100.00%Get Alert
03/16/2023PMCBAYQ4-$0.34-$0.30-$0.300.00%$0.00$0.00Get Alert
11/14/2022PMCBAYQ3-$0.33-$0.30-$0.286.67%$0.00$0.00Get Alert
08/11/2022PMCBAYQ2-$0.34-$0.30-$0.31-3.33%$0.00$0.00Get Alert
05/12/2022PMCBAYQ1-$0.25-$0.31-$0.32-3.23%$0.00$0.00Get Alert
03/17/2022PMCBAYQ4-$0.23-$0.26-$0.34-30.77%$0.00$6.43M$0.00-100.00%Get Alert
11/10/2021PMCBAYQ3-$0.17-$0.26-$0.33-26.92%$0.00$6.25M$0.00-100.00%Get Alert
08/12/2021PMCBAYQ2-$0.16-$0.27-$0.34-25.93%$0.00$0.00Get Alert
05/13/2021PMCBAYQ1-$0.19-$0.24-$0.25-4.17%$0.00$0.00Get Alert
03/25/2021PMCBAYQ4-$0.43-$0.20-$0.23-15.00%$0.00$0.00Get Alert
11/05/2020PMCBAYQ3-$0.38-$0.17-$0.170.00%$0.00$0.00Get Alert
08/10/2020PMCBAYQ2-$0.35-$0.24-$0.1633.33%$0.00$0.00Get Alert
05/11/2020PMCBAYQ1-$0.37-$0.30-$0.1936.67%$0.00$0.00Get Alert
03/12/2020PMCBAYQ4-$0.32-$0.39-$0.43-10.26%$0.00$0.00Get Alert
11/05/2019PMCBAYQ3-$0.34-$0.37-$0.38-2.70%$0.00$0.00Get Alert
08/07/2019PMCBAYQ2-$0.30-$0.37-$0.355.41%$0.00$0.00Get Alert
05/08/2019PMCBAYQ1-$0.32-$0.34-$0.37-8.82%$0.00$0.00Get Alert
Q

When is CymaBay Therapeutics (NASDAQ:CBAY) reporting earnings?

A

CymaBay Therapeutics (CBAY) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 7, 2023 for Q3.

Q

What were the latest earnings per share (EPS) for CymaBay Therapeutics (NASDAQ:CBAY)?

A

CymaBay Therapeutics (CBAY) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 7, 2023 for Q3 and the Actual EPS was $-0.32, which missed the estimate of $-0.30.

Q

What were CymaBay Therapeutics’s (NASDAQ:CBAY) revenues?

A

CymaBay Therapeutics (CBAY) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 7, 2023 for Q3 and the Actual Revenue was $0K, which hit the estimate of $0K.

Browse earnings estimates, EPS, and revenue on all stocks.